首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

深層腦部刺激器市場規模、佔有率和成長分析（按產品類型、應用、最終用戶和地區分類）：產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898150

深層腦部刺激器市場規模、佔有率和成長分析（按產品類型、應用、最終用戶和地區分類）：產業預測（2026-2033 年）

Deep Brain Stimulation Devices Market Size, Share, and Growth Analysis, By Product Type (Single-channel DBS Devices, Dual-channel DBS Devices), By Application (Epilepsy, Pain Management), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球深層腦部刺激器市場規模預計在 2024 年達到 16.8 億美元，從 2025 年的 18.3 億美元成長到 2033 年的 37.1 億美元，在預測期（2026-2033 年）內複合年成長率為 9.2%。

全球深層腦部刺激器市場正經歷顯著成長，這主要得益於帕金森氏症和自發性震顫等神經系統疾病發病率的上升。這些日益嚴峻的健康挑戰推動了對深部腦部刺激等有效治療方法的需求。該領域的技術創新，例如可充電設備和精準靶向系統，正在改善治療效果、安全性和有效性。患者和醫療服務提供者對深部腦部刺激作為一種可行的治療選擇，其顯著優勢（例如緩解症狀和減少藥物依賴性）的接受度不斷提高，進一步推動了市場擴張。此外，已開發市場和新興市場有利的報銷政策以及不斷成長的醫療保健投資，也為製造商提供了有效拓展市場和豐富產品線的良機。

全球深層腦部刺激器市場促進因素

全球深層腦部刺激器市場的發展動力源自於持續不斷的技術創新，這些創新不僅改善了病患的治療效果，也拓展了可治療疾病的範圍。近期的進展催生了許多先進功能，例如封閉回路型系統和自適應演算法，以及更精確的標靶系統和更精細的刺激參數。這些技術進步使得個人化治療策略成為可能，從而改善症狀控制，提高整體療效，並最大限度地減少副作用。由此帶來的治療效果和安全性日益提升，也促進了深層腦部刺激器在各個醫學領域的廣泛應用。

阻礙因素全球深層腦部刺激器市場的因素

全球深層腦部刺激器市場面臨諸多限制因素，主要源自於這些設備的複雜性以及手術植入所需的極高精準度。設備相關費用，包括硬體、導線和相關程式系統，可能相當可觀。此外，手術本身高成本，需要專用設備、專屬手術室資源以及全面的術後照護。這些經濟負擔阻礙了設備的普及和可近性，尤其是在資源匱乏地區和醫療保險覆蓋不足的人群中，限制了深部腦部刺激技術的潛在應用範圍和普及程度。

全球深層腦部刺激器市場趨勢

全球深部腦部刺激（DBS）設備市場正經歷顯著成長，主要促進因素是帕金森氏症、自發性震顫和肌張力不全症等神經系統疾病盛行率的上升。人口老化、慢性病盛行率的快速成長以及環境毒素暴露的增加也是推動這一成長的因素。隨著患者和醫療機構擴大選擇DBS作為一種高效的治療方案，對DBS設備的需求預計將持續成長。這一趨勢凸顯了先進醫療技術在應對複雜神經系統疾病挑戰方面發揮的關鍵作用，也使DBS市場成為一個充滿創新和投資潛力的領域。

美敦力公司（美國）
雅培實驗室（美國）
波士頓科學公司（美國）
Aleva Neurotherapeutics SA（瑞士）
北京平斯醫療有限公司（中國）
Brainsway有限公司（美國）
NeuroPace公司（美國）
功能神經調控有限公司（美國）
NeuroSigma公司（美國）
北京品馳醫療器材有限公司（中國）
SceneRay Corporation Ltd.（中國）
智人引導腦部刺激（荷蘭）
雷尼紹有限公司（英國）
Synapse Biomedical Inc.（美國）
Deep Brain Innovations LLC（美國）
Newronika SpA（義大利）
Nexstim Plc（芬蘭）
Neuronetics公司（美國）
Magstim有限公司（英國）
Bioinduction Ltd.（英國）

結論與建議

簡介目錄

Product Code: SQMIG35G2217

Global Deep Brain Stimulation Devices Market size was valued at USD 1.68 Billion in 2024 and is poised to grow from USD 1.83 Billion in 2025 to USD 3.71 Billion by 2033, growing at a CAGR of 9.2% during the forecast period (2026-2033).

The global deep brain stimulation devices market is experiencing significant growth, influenced by the rising incidence of neurological disorders such as Parkinson's disease and essential tremor. This growing health concern has heightened the demand for effective treatments like deep brain stimulation. Technological innovations within the field, including rechargeable devices and enhanced targeting systems, have improved treatment outcomes, safety, and efficacy. Increasing acceptance of deep brain stimulation as a viable therapeutic option among patients and healthcare providers is further driving market expansion, as it offers substantial benefits like symptom relief and reduced medication reliance. Additionally, favorable reimbursement policies and rising healthcare investments in both developed and emerging markets present robust opportunities for manufacturers to broaden their reach and enhance their product offerings effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segments Analysis

Global Deep Brain Stimulation Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Single-channel DBS Devices and Dual-channel DBS Devices. Based on Application, the market is segmented into Epilepsy, Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinson's Disease, Depression, Dystonia and Others. Based on End User, the market is segmented into Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market is propelled by continual innovations in technology that enhance patient outcomes and broaden the spectrum of treatable conditions. Recent advancements have led to the creation of more accurate targeting systems and refined stimulation parameters, in addition to the incorporation of sophisticated features like closed-loop systems and adaptive algorithms. These technological enhancements facilitate personalized treatment strategies, leading to improved symptom management, greater overall efficacy, and minimized side effects. As a result, the therapy is becoming increasingly effective and safe, contributing to the growing adoption of deep brain stimulation devices across various medical disciplines.

Restraints in the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market faces significant restraints primarily due to the intricate nature of these devices and the precision required for their surgical implantation. The expenses associated with the devices, which encompass the hardware, leads, and related programming systems, can be considerable. Furthermore, the surgical procedures themselves involve high costs, necessitating specialized equipment, dedicated operating room resources, and comprehensive post-operative care. Such financial burdens create barriers to affordability and accessibility, especially in areas where healthcare resources are scarce or insurance coverage is insufficient, limiting the potential reach and adoption of deep brain stimulation technologies.

Market Trends of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation (DBS) Devices market is experiencing significant growth, primarily fueled by the rising prevalence of neurological disorders such as Parkinson's disease, essential tremor, and dystonia. Contributing factors include an aging population, the surge in chronic disease prevalence, and heightened exposure to environmental toxins. As patients and healthcare providers increasingly turn to DBS as a highly effective treatment option, the demand for these devices is expected to expand. This trend underscores the critical role of advanced medical technologies in addressing complex neurological challenges, positioning the DBS market for continued innovation and investment in the foreseeable future.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis

Global Deep Brain Stimulation Devices Market Size by Product Type & CAGR (2026-2033)

Market Overview
Single-channel DBS Devices
Dual-channel DBS Devices

Global Deep Brain Stimulation Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Epilepsy
Pain Management
Essential Tremor
Obsessive Compulsive Disorder (OCD)
Parkinson's Disease
Depression
Dystonia
Others

Global Deep Brain Stimulation Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers
Others

Global Deep Brain Stimulation Devices Market Size & CAGR (2026-2033)

North America (Product Type, Application, End User)
- US
- Canada
Europe (Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic Plc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing PINS Medical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainsway Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Functional Neuromodulation Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroSigma, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing Pinchi Medical Equipment Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SceneRay Corporation Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sapiens Steering Brain Stimulation (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Renishaw plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Deep Brain Innovations LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Newronika S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexstim Plc (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Magstim Company Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioinduction Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments